Literature DB >> 6232308

Androgen plasma levels in male diabetics.

S Andò, R Rubens, R Rottiers.   

Abstract

Plasma level of androgens were studied in 47 normal male controls (20-50 yr-old; mean age 38 yr) and in a group of forty-one male diabetics (23-55 yr-old; mean age: 37.5 yr). Of these 36 showed type II and 5 type I diabetes. The results showed that while the mean basal plasma LH was unchanged, there was a decrease in testosterone levels in the diabetics. Moreover, testosterone binding globulin (TeBG) capacity appeared to be augmented and, as a consequence, the apparent free testosterone concentration (AFTC) was markedly decreased. It is interesting to note that the anomalies in androgen secretion observed are rather similar to those found in elderly man and could play some role (with other factors) in the onset of the frequent sexual disturbances in male diabetics.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232308     DOI: 10.1007/BF03348370

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  DEHYDROEPIANDROSTERONE IN OBESE DIABETICS.

Authors:  J SONKA; I GREGORVA; J PAV; F SKRHA
Journal:  Lancet       Date:  1964-07-04       Impact factor: 79.321

2.  [TESTICULAR FUNCTION OF THE IMPOTENT DIABETIC. I. URINARY ELIMINATION OF 17-KETOSTEROIDS AND GONADOTROPINS].

Authors:  J P BATAILLE
Journal:  Ann Endocrinol (Paris)       Date:  1963 Jul-Aug       Impact factor: 2.478

3.  Prolactin and adrenal androgen secretion.

Authors:  A Vermeulen; S Ando
Journal:  Clin Endocrinol (Oxf)       Date:  1978-04       Impact factor: 3.478

4.  Radioimmunoassay of 17beta-hydroxy-5alpha-androstan-3-one, 4-androstene-3,17-dione, dehydroepiandrosterone, 17-hydroxyprogesterone and progesterone and its application to the human male plasma.

Authors:  A Vermeulen; L Verdonck
Journal:  J Steroid Biochem       Date:  1976-01       Impact factor: 4.292

5.  Further studies on Leydig cell function in old age.

Authors:  R Rubens; M Dhont; A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

Review 6.  Testosterone in plasma. A physiopathological study.

Authors:  A Vermeulen
Journal:  Verh K Acad Geneeskd Belg       Date:  1973

7.  Sexual dysfunction in diabetic men.

Authors:  R C Kolodny; C B Kahn; H H Goldstein; D M Barnett
Journal:  Diabetes       Date:  1974-04       Impact factor: 9.461

8.  Testosterone secretion and metabolism in male senescence.

Authors:  A Vermeulen; R Rubens; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

9.  The apparent free testosterone concentration, an index of androgenicity.

Authors:  A Vermeulen; T Stoïca; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

10.  Impotence and diabetes. Studies of androgenic function in diabetic impotent males.

Authors:  I Faerman; O Vilar; M A Rivarola; J M Rosner; M N Jadzinsky; D Fox; A P Lloret; L Bernstein-Hahn; D Saraceni
Journal:  Diabetes       Date:  1972-01       Impact factor: 9.461

View more
  11 in total

Review 1.  Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.

Authors:  C Cattabiani; S Basaria; G P Ceda; M Luci; A Vignali; F Lauretani; G Valenti; R Volpi; M Maggio
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

Review 2.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

3.  A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study).

Authors:  Ali S Murad; George Davey Smith; Sarah J Lewis; Angela Cox; Jenny L Donovan; David E Neal; Freddie C Hamdy; Richard M Martin
Journal:  Int J Mol Epidemiol Genet       Date:  2010-04-01

4.  Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study.

Authors:  D Simon; P Preziosi; E Barrett-Connor; M Roger; M Saint-Paul; K Nahoul; L Papoz
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

5.  Relationships of circulating sex hormone-binding globulin with metabolic traits in humans.

Authors:  Andreas Peter; Konstantinos Kantartzis; Jürgen Machann; Fritz Schick; Harald Staiger; Fausto Machicao; Erwin Schleicher; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan
Journal:  Diabetes       Date:  2010-09-14       Impact factor: 9.461

6.  Diabetes mellitus and risk of prostate cancer: a meta-analysis.

Authors:  S Bonovas; K Filioussi; A Tsantes
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

7.  The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran.

Authors:  Mohammad Reza Mirzaei; Massoud Amini; Ashraf Aminorroaya
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

8.  Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study.

Authors:  A J Swerdlow; S P Laing; Z Qiao; S D Slater; A C Burden; J L Botha; N R Waugh; A D Morris; W Gatling; E A Gale; C C Patterson; H Keen
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

9.  Diabetes mellitus and prostate cancer risk among older men: population-based case-control study.

Authors:  A L Coker; M Sanderson; W Zheng; M K Fadden
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

10.  Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes.

Authors:  Entesar Oa El Saghier; Salah E Shebl; Olfat A Fawzy; Ihab M Eltayeb; Lamya Ma Bekhet; Abdelnasser Gharib
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2015-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.